Paid Clinical Trials Great Falls
Discover 89 paid clinical trials in Great Falls, Montana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Observational StudyMulti-Institutional Registry for Prostate Cancer Radiosurgery
Sponsor:
RPCR, Inc.
Location:
Code:
NCT01226004
Conditions
Prostate Cancer Early Risk Treated by Radiosurgery
Prostate Cancer Intermediate Risk Treated by Radiosurgery
Eligibility Criteria
Sex: Male
Age: 18 - 70+
Healthy Volunteers: Not accepted
Nivolumab & IpilimumabTesting Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05112601
Conditions
Endometrial Adenocarcinoma
Endometrial Clear Cell Adenocarcinoma
Endometrial Dedifferentiated Carcinoma
Endometrial Endometrioid Adenocarcinoma
Endometrial Mixed Cell Adenocarcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Ipilimumab
Magnetic Resonance Imaging
Nivolumab
SUI-100™Evaluating SUI-100™, A Non-Invasive Device for the Treatment of Stress Urinary Incontinence
Sponsor:
Acoustic Wave Cell Therapy, Inc.
Location:
Code:
NCT06862648
Conditions
Stress Urinary Incontinence (SUI)
Eligibility Criteria
Sex: Female
Age: 22 - 70+
Healthy Volunteers: Not accepted
Interventions
Acoustic Stimulation Therapy Device
Sham Acoustic Stimulation Therapy Device
ObeldesivirStudy of Obeldesivir to Treat Children With Respiratory Syncytial Virus (RSV) Infection
Sponsor:
Gilead Sciences
Location:
Code:
NCT06784973
Conditions
RSV Infection
Eligibility Criteria
Sex: All
Age: 0 - 5
Healthy Volunteers: Not accepted
Interventions
Obeldesivir
Obeldesivir Placebo
Targeted TherapyTargeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05564377
Conditions
Advanced Malignant Solid Neoplasm
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Locally Advanced Malignant Solid Neoplasm
Malignant Female Reproductive System Neoplasm
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Alpelisib
Binimetinib
Biopsy Procedure
Biospecimen Collection
Bone Marrow Aspiration
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Ipatasertib & Megestrol AcetateTesting the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05538897
Conditions
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Metastatic Endometrial Endometrioid Adenocarcinoma
Recurrent Endometrial Endometrioid Adenocarcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Ipatasertib
Magnetic Resonance Imaging
Megestrol Acetate
Nivolumab & IpilimumabA Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT02339571
Conditions
Stage III Cutaneous Melanoma AJCC v7
Stage IV Cutaneous Melanoma AJCC v6 and v7
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biospecimen Collection
Computed Tomography
Echocardiography Test
Ipilimumab
Magnetic Resonance Elastography
MyeloMATCHTesting the Effects of Novel Therapeutics for Newly Diagnosed, Untreated Patients With High-Risk Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05554406
Conditions
Acute Myeloid Leukemia
Acute Myeloid Leukemia Arising From Previous Myelodysplastic/Myeloproliferative Neoplasm
Acute Myeloid Leukemia Post Cytotoxic Therapy
Acute Myeloid Leukemia, Myelodysplasia-Related
Eligibility Criteria
Sex: All
Age: 18 - 59
Healthy Volunteers: Not accepted
Interventions
Azacitidine
Biospecimen Collection
Bone Marrow Aspiration
Cytarabine
Daunorubicin Hydrochloride
BiomarkersUsing Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
Sponsor:
ECOG-ACRIN Cancer Research Group
Location:
Code:
NCT04462406
Conditions
Advanced Melanoma
Clinical Stage III Cutaneous Melanoma AJCC v8
Clinical Stage IV Cutaneous Melanoma AJCC v8
Melanoma of Unknown Primary
Pathologic Stage IIIB Cutaneous Melanoma AJCC v8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Ipilimumab
Nivolumab
Patient Observation
Pembrolizumab
Selumetinib & OlaparibTesting the Use of the Combination of Selumetinib and Olaparib or Selumetinib Alone Targeted Treatment for RAS Pathway Mutant Recurrent or Persistent Ovarian and Endometrial Cancers, A ComboMATCH Treatment Trial
Sponsor:
National Cancer Institute (NCI)
Location:
Code:
NCT05554328
Conditions
Recurrent Endometrial Carcinoma
Recurrent Fallopian Tube Carcinoma
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Biopsy Procedure
Biospecimen Collection
Bone Marrow Aspiration and Biopsy
Computed Tomography
Echocardiography Test